<DOC>
	<DOC>NCT01357356</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy and safety of SER120 nasal spray formulations in patients with nocturia for a total duration of 14 weeks.</brief_summary>
	<brief_title>Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia</brief_title>
	<detailed_description />
	<mesh_term>Nocturia</mesh_term>
	<criteria>Male and female 50 years or older Nocturia of 6 or more months duration averaging greater than 2 nocturic episode per night CHF Diabetis Insipidus Renal Insufficiency Hepatic Insufficiency Incontinence Illness requiring systemic steroids Malignancy within the past 5 years Sleep Apnea Nephrotic Syndrome Unexplained Pelvic Mass Urinary Bladder Neurological dysfunction Urinary Bladder Surgery or Radiotherapy Pregnant or Breast Feeding</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>